Questions with no answer at all. Not questions with no accepted answer — those are elsewhere.
Conditions: PeptideMeter · Tianjin Finder Chemical. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is…
Numbers first: Medutest · 99.4%. Before I write this off, I want to check whether it is a known failure mode. I have the lot number, the certificate and the date, and…
Setup, so nobody has to ask: survodutide · semaglutide. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know…
What I have: a GLP-1 receptor agonist · SELECT. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know…
The specifics, since they change the answer: AST · ALT · a GLP-1 receptor agonist. The comparison I want does not seem to exist anywhere in a form I can evaluate. I…
Details up front: potassium · three weeks · mazdutide. An unexpected observation, and I would like a differential rather than reassurance. The conditions were within…
What I have: a GLP-1 receptor agonist · sixteen weeks · room temperature. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this…
What I am working with: WXT · KP · New Zealand. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain either…
Setup, so nobody has to ask: 95 kg · 1,400 kcal. The units are where I keep going wrong, so please be explicit about them. I have sanity-checked the order of…
What I have: a 31G needle · dulaglutide · 8 mg/mL. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
Concretely: Tianjin · Poland. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s interpretation…
Stated plainly: 97.1% · cagrilintide · TFC. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not tight, and my…
Numbers first: REDEFINE-1 · early satiety · 2.4 mg. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear…
Concretely: 96.4% · tirzepatide. I want the working, not the result — I need to be able to redo it with different numbers. I care about the precision as well as the…
The particulars: liraglutide · minus 20 °C. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested that", I would…
The method section is present, which is unusual enough that I want to make use of it. This has the shape of a fact but I cannot find its origin. What I found instead…
For reference: GGT · albumin-to-creatinine ratio · dulaglutide. I would like the axes of comparison first and the recommendation second. I have tried the first option…
Conditions: aspartimide formation · liraglutide · 30 °C. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the…
Conditions: date of analysis · QST. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am being…
I have photographs before and after reconstitution if the visual detail matters. I would like to set this up properly once, rather than adjust it repeatedly. My…
Stated plainly: JEEP · Nantong · Norway. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work…
Setup, so nobody has to ask: sampling plan · ERP. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum…
I am comparing a supplier certificate against an independent result on the same lot. I would like to know the limits of what can be inferred from this. What I am…
Conditions: QST · Shanghai Wibson Biotechnology. I would like the axes of comparison first and the recommendation second. I have tried the first option and it works;…